Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,400.96
(
-0.16%
)
US TECH 100
28,532.79
(
0.86%
)
Dow Jones
49,760.56
(
0.11%
)
Brent Oil
104.75
(
-0.95%
)
Bitcoin
81,084.71
(
0.74%
)
News Focus
News Focus
Post# of 6105
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122973
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: dewophile post# 6079

Thursday, 04/30/2026 11:02:04 AM

Thursday, April 30, 2026 11:02:04 AM

Post# of 6105
The US patent on Glecaprevir’s crystal formulations (9,321,807) runs until 12/5/2035. As far as I know, this is the longest-running patent relevant to Mavyret sales in the US. Patents that ABBV licensed from ENTA in some other countries may expire later.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent ENTA News
More ENTA News